BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25714013)

  • 21. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
    Kang GH; Lee S; Shim YH; Kim JC; Ro JY
    Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
    Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
    J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
    Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
    Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
    Li X; Zhang W; Song J; Zhang X; Ran L; He Y
    Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.
    Eftang LL; Klajic J; Kristensen VN; Tost J; Esbensen QY; Blom GP; Bukholm IR; Bukholm G
    BMC Cancer; 2016 Mar; 16():225. PubMed ID: 26984265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker.
    Raja UM; Gopal G; Rajkumar T
    Asian Pac J Cancer Prev; 2012; 13(11):5563-8. PubMed ID: 23317218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer.
    Xu X; Chang X; Xu Y; Deng P; Wang J; Zhang C; Zhu X; Chen S; Dai D
    Int J Clin Oncol; 2020 Jun; 25(6):1105-1114. PubMed ID: 32206938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway.
    Fan Y; Zhan Q; Xu H; Li L; Li C; Xiao Q; Xiang S; Hui T; Xiang T; Ren G
    Biochem Biophys Res Commun; 2016 Jun; 474(4):660-666. PubMed ID: 27150632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
    Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
    Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
    Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
    Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
    Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
    Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
    Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylated CpG site count of dapper homolog 1 (DACT1) promoter prediction the poor survival of gastric cancer.
    Deng J; Liang H; Zhang R; Ying G; Xie X; Yu J; Fan D; Hao X
    Am J Cancer Res; 2014; 4(5):518-27. PubMed ID: 25232493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley.
    Wani M; Afroze D; Makhdoomi M; Hamid I; Wani B; Bhat G; Wani R; Wani K
    Asian Pac J Cancer Prev; 2012; 13(8):4177-81. PubMed ID: 23098428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.